Effects of a Long Term Dietary Portfolio and of Sequential Removal of Food Components From the Diet
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the long term effectiveness of the dietary portfolio, consisting of viscous fibers, soy products, nuts and plant sterols, as well as the effects of removing single food components from the dietary portfolio on cholesterol reduction and other cardiovascular risk factors.
| Condition | Intervention | Phase |
|---|---|---|
|
Hyperlipidemia Cardiovascular Diseases Hypercholesterolemia |
Procedure: Dietary portfolio of cholesterol-lowering foods |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Long-Term Effect of Viscous Fibers, Soy Protein, and Plant Sterol Foods in Combination on Serum Cholesterol and Other Risk Factors for Cardiovascular Disease |
- Total cholesterol
- LDL cholesterol
- C-reactive protein
- Blood pressure
- Body Weight
- Apolipoprotein A1 and B
- Lp(a)
- Routine Biochemistry and hematology measurements
- Compliance to dietary portfolio components
- 24 hour urinary markers and electrolytes
- Oxidative stress markers
| Estimated Enrollment: | 66 |
We have shown in 1-month metabolic studies that a dietary portfolio, consisting of soy products, viscous fibers, almonds and plant sterols in the form of margarine, can lower cholesterol to the same extent as first generation statins (cholesterol-lowering drugs). However, the long-term effectiveness of the dietary portfolio is not known. Furthermore, it is not known to what extent each of the food components contribute to the cholesterol reductions observed. We wish to therefore evaluate the long term effects of the dietary portfolio as well as the effects of removing single food components from the dietary portfolio on cholesterol reduction and other cardiovascular risk factors. We believe the removal of single food components will result in a reduction of the cholesterol-lowering effect to a similar extent as predicted with the cholesterol reductions observed when the food component is consumed alone.
Method:
66 subjects will be recruited for a long-term 5-year dietary portfolio trial. The active dietary components consist of viscous fibers (including oat bran), soy products (including soy milk), almonds and plant sterols (sterol-enriched margarine). Lipids, blood pressure, body weight, and routine biochemical and hematology analyses will be performed over the 5 year period, with lipids and blood pressure measured at 2 monthly intervals. 40-50 subjects on the long term dietary portfolio study, all of whom will have been on the diet for at least 1 year, will be asked to remove a specific food component from their regular dietary portfolio for a 10 week period. After the 10 week period, subjects will be asked return to the normal dietary portfolio with all food components consumed and continue on the long-term dietary portfolio.
Bloods will be taken at weeks 0, 6 and 10 of the food component removal period; and at 2-monthly intervals for 20 weeks prior to and after the 10 week period while on the long-term dietary portfolio with all food components.
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy adult men and postmenopausal women currently enrolled in the long-term portfolio study
- Body mass index <32 kg/m2
- Constant body weight over last 6 months preceding the onset of the study
- Fasting LDL-cholesterol concentration >4.1 mmol/L at diagnosis
Exclusion Criteria:
- women of child-bearing potential
- major cardiovascular event (stroke or myocardial infarction)
- positive molecular diagnosis of familial hypercholesterolemia
- secondary causes of hypercholesterolemia (hypothyroidism, unless treated & on a stable dose of L-thyroxine, renal or liver disease)
- use of cholesterol-lowering medications
- serum triglycerides >4.5 mmol/L
- blood pressure > 145/90 mmHg
- diabetes and/or major disorders such as liver disease, renal failure or cancer
- major surgery <6 months prior to randomization
- alcohol consumption >2 drinks per day
Contacts and Locations| Canada, Ontario | |
| Clinical Nutrition & Risk Factor Modification Centre, St. Michael's Hospital Health Centre | |
| Toronto, Ontario, Canada, M5C 2T2 | |
| Principal Investigator: | David JA Jenkins, MD, PhD, DSc | Department of Nutritional Sciences, Faculty of Medicine, University of Toronto |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | David Jenkins, Principle Investigator, University of Toronto |
| ClinicalTrials.gov Identifier: | NCT00438893 History of Changes |
| Other Study ID Numbers: | REB 03-043, HC-CT#100934 |
| Study First Received: | February 20, 2007 |
| Last Updated: | June 12, 2012 |
| Health Authority: | Canada: St. Michael's Hospital Research Ethics Board Canada: Natural Health Products Directorate |
Keywords provided by University of Toronto:
|
Viscous dietary fiber Soy protein Nuts Plant sterols |
Dietary Portfolio Compliance Blood lipids Blood pressure |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Hypercholesterolemia Hyperlipidemias |
Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013